References
- Hirschfeld RMA. Management of sexual side effects of antidepressant therapy. J Clin Psychiatry. 1999;60:27–30.
- Heiman JR. Sexual dysfunction: overview of prevalence, etiological factors, and treatments [Internet]. J Sex Res. Taylor & Francis Group. 2002;39(1):p. 73–78. [cited 2021 Oct 6]. Available from: https://www.tandfonline.com/doi/abs/10.1080/00224490209552124
- El-Sakka AI. Erectile dysfunction, depression, and ischemic heart disease: does the existence of one component of this triad necessitate inquiring the other two? (CME). J Sex Med. 2011;8(4):937–940.
- El-Sakka AI, Shamloul R, Yassin AA. Erectile dysfunction, cardiovascular diseases and depression: interaction of therapy [Internet]. Expert Opin Pharmacother. Taylor & Francis. 200910(13):p. 2107–2117. [cited 2021 Apr 11]. Available from: https://www.tandfonline.com/doi/abs/10.1517/14656560903089326
- Bakr AM, El-Sakka AA, El-Sakka AI. Considerations for prescribing pharmacotherapy for the treatment of erectile dysfunction [Internet]. Expert Opin Pharmacother Taylor & Francis. 2021;22(7):821–834. Available from: https://doi.org/https://doi.org/10.1080/14656566.2020.1851365
- Bromet E, Andrade LH, Hwang I, et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med [Internet]. 2011;9(1):1–16. cited 2021 Oct 6. Available from: https://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-9-90
- Segraves RT, Balon R. Antidepressant-induced sexual dysfunction in men. Pharmacol Biochem Behav [Internet]. 2014;121:132–137. Available from: https://doi.org/http://dx.doi.org/10.1016/j.pbb.2013.11.003.
- Khazaie H, Rezaie L, Rezaei Payam N, et al. Antidepressant-induced sexual dysfunction during treatment with fluoxetine, sertraline and trazodone; a randomized controlled trial. Gen Hosp Psychiatry. 2015;37(1):40–45. cited 2021 Oct 5.
- Atlantis E, Sullivan T. Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis. J Sex Med [Internet]. 2012;9(6):1497–1507. Available from: https://pubmed.ncbi.nlm.nih.gov/22462756/
- Keltner NL, McAfee KM, Taylor CL. Mechanisms and treatments of SSRI-induced sexual dysfunction. Perspect Psychiatr Care. [Internet]. 2002;38(3):111–116. cited 2021 Oct 8. Available from: https://search.proquest.com/openview/43c709dc091b35ed5a54016c6a1e60e5/1?pq-origsite=gscholar&cbl=48941
- Boyarsky B, Hirschfeld R. The management of medication-induced sexual dysfunction. Essent Psychopharmacol [Internet]. 2000;3:151. cited 2021 Oct 8. Available from: http://www.hormonebalance.org/images/documents/Boyarsky2000MedinducedSexdys.pdf.
- Wang Q, Dwivedi Y. Advances in novel molecular targets for antidepressants. Prog Neuro-Psychopharmacol Biol Psychiatry Elsevier. 2021;104:110041.
- Yalin N, Young AH. Pharmacological treatment of bipolar depression: what are the current and emerging options? Neuropsychiatr Dis Treat [Internet]. 2020;16:1459–1472. cited 2021 Oct 6. Available from: /pmc/articles/PMC7294105/
- Wong J, Motulsky A, Abrahamowicz M, et al. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system. BMJ [Internet]. 2017;356:603. cited 2021 Oct 6. Available from: https://www.bmj.com/content/356/bmj.j603
- Jannini TB, Di Lorenzo G, Bianciardi E, et al. Off-label uses of selective serotonin reuptake inhibitors (SSRIs). Curr Neuropharmacol. 2022;20(4):693–712.
- Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol. 2009;29(3):259–266.
- Lee KU, Lee YM, Nam JM, et al. Antidepressant-induced sexual dysfunction among newer antidepressants in a naturalistic setting. Psychiatry Investig. 2010;7(1):55–59.
- Gregorian RS, Golden KA, Bahce A, et al. Antidepressant-induced sexual dysfunction [Internet]. Ann Pharmacother SAGE Publications; 2002;36(10):p. 1577–1589. [cited 2021 Oct 6]. Available from: https://journals.sagepub.com/doi/abs/10.1345/aph.1a195?casa_token=CHko8tc7cbIAAAAA%3AKi1Lz6lD6mrAUq87-0pAusMsdeKWTCOFlFrvf9ddCcTVcquq0LjlaWJclsCZIxGpImTB9M-GWbUZzeY
- Keks NA, Hope J, Culhane C. Management of antidepressant induced sexual dysfunction. Australas Psychiatry. 2014;22(6):525–528.
- Graf H, Walter M, Metzger CD, et al. Antidepressant-related sexual dysfunction - perspectives from neuroimaging. Pharmacol Biochem Behav. 2014;121:138–145.
- Abler B, Seeringer A, Hartmann A, et al. Neural correlates of antidepressant-related sexual dysfunction: a placebo-controlled fMRI study on healthy males under subchronic paroxetine and bupropion. Neuropsychopharmacology [Internet]. 2011;36(9):1837–1847. cited 2021 Oct 7. Available from: https://www.nature.com/articles/npp201166
- Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry. [Internet]. 2000;57(11):1012–1030. cited 2021 Oct 6. Available from: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/481665
- Stahl SM. The psychopharmacology of sex, part 1: neurotransmitters and the 3 phases of the human sexual response [Internet]. J Clin Psychiatry. 2001;62(2):80–81. [cited 2021 Oct 6]. Available from: https://www.psychiatrist.com/wp-content/uploads/2021/02/16586_psychopharmacology-sex-part-neurotransmitters-phases.pdf
- Taylor MJ, Rudkin L, Hawton K. Strategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trials. J Affect Disord. 2005;88(3):241–254.
- Taylor MJ, Rudkin L, Bullemor-Day P, et al. Strategies for managing sexual dysfunction induced by antidepressant medication. Cochrane Database Syst Rev. 2013;5:CD003382 doi:https://doi.org/10.1002/14651858.CD003382.
- Chokka PR, Hankey JR. Assessment and management of sexual dysfunction in the context of depression. Ther Adv Psychopharmacol. 2018;8(1):13–23.
- Fusco F, Franco M, Longo N, et al. The impact of non-urologic drugs on sexual function in men. Arch Ital Di Urol E Androl. 2014;86(1):50–55.
- Kennedy SH, Dickens SE, Eisfeld BS, et al. Sexual dysfunction before antidepressant therapy in major depression. J Affect Disord [Internet]. 1999;56(2–3):201–208. cited 2021 Aug 17. Available from: https://pubmed.ncbi.nlm.nih.gov/10701478/
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5 (Vol. 5). Washington, DC: American psychiatric association. 2013. Available from https://doi.org/10.1176/appi.books.9780890425596
- Word Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Heal Organ. 1992.
- Mathew RJ, Weinman ML. Sexual dysfunctions in depression. Arch Sex Behav. [Internet]. 1982;11(4):323–328. cited 2021 Aug 29. Available from: https://pubmed.ncbi.nlm.nih.gov/7149967/
- Angst J. Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol [Internet]. 1998;13:S1–S4. cited 2021 Aug 17. Available from: https://pubmed.ncbi.nlm.nih.gov/9728667/
- Araujo AB, Durante R, Feldman HA, et al. The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts male aging study. Psychosom Med [Internet]. 1998;60(4):458–465. cited 2021 Aug 30. Available from: https://journals.lww.com/psychosomaticmedicine/fulltext/1998/07000/the_relationship_between_depressive_symptoms_and.11.aspx
- Belujon P, Grace AA. Dopamine system dysregulation in major depressive disorders. Int J Neuropsychopharmacol. [Internet]. 2017;20(12):1036–1046. cited 2022 Mar 9. Available from: https://academic.oup.com/ijnp/article/20/12/1036/3901225
- Thase ME, Reynolds CF, Jennings JR, et al. Nocturnal penile tumescence is diminished in depressed men. Biol Psychiatry [Internet]. 1988;24(1):33–46. cited 2021 Aug 28. Available from: https://pubmed.ncbi.nlm.nih.gov/3370276/
- Simopoulos EF, Trinidad AC. Male erectile dysfunction: integrating psychopharmacology and psychotherapy. Gen Hosp Psychiatry [Internet]. 2013;35(1):33–38. Available from: https://doi.org/http://dx.doi.org/10.1016/j.genhosppsych.2012.08.008
- Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol [Internet]. 1994;151:54–61. cited 2021 Aug 28. Available from: https://pubmed.ncbi.nlm.nih.gov/8254833/
- Krishnan KRR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry [Internet]. 1997;154:497–501. cited 2021 Aug 28. Available from: https://pubmed.ncbi.nlm.nih.gov/9090336/
- Thase ME, Howland RH. Biological processes in depression: An updated review and integration. In Beckham EE, Leber WR, editors. Handbook of depression (). 1995:p. 213–279. [cited 2021 Aug 28]. Available from: https://psycnet.apa.org/record/1995-98831-008
- Kennedy SH, Rizvi S. Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol. 2009;29(2):157–164.
- McLean JD, Forsythe RG, Kapkin IA. Unusual side effects of clomipramine associated with yawning. Can J Psychiatry. 1983;28(7):569–570.
- Montejo AL, Montejo L, Navarro-Cremades F. Sexual side-effects of antidepressant and antipsychotic drugs. Curr Opin Psychiatry. 2015;28(6):418–423.
- Delgado PL, Brannan SK, Mallinckrodt CH, et al. Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry [Internet]. 2005;66(6):686–692. cited 2021 Aug 28. Available from: https://www.psychiatrist.com/jcp/depression/sexual-functioning-assessed-double-blind-placebo/
- Kennedy SH, Eisfeld BS, Dickens SE, et al. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry. 2000;61(4):276–281.
- Bala A, Nguyen HMT, Hellstrom WJG. Post-SSRI sexual dysfunction: a literature review. Sex Med Rev. 2018;6(1):29–34.
- Healy D, Bahrick A, Bak M, et al. Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin. Int J Risk Saf Med. 2021;33(1):65–76.
- Bijlsma EY, Chan JSW, Olivier B, et al. Sexual side effects of serotonergic antidepressants: mediated by inhibition of serotonin on central dopamine release? Pharmacol Biochem Behav. 2014;121:88–101.
- Clayton A, Keller A, McGarvey EL. Burden of phase-specific sexual dysfunction with SSRIs. J Affect Disord. 2006;91(1):27–32.
- Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review [Internet]. J Clin Psychopharmacol. 1999;19(1):67–85. [cited 2021 Aug 28]. Available from: https://journals.lww.com/psychopharmacology/Fulltext/1999/02000/Serotonin_Reuptake_Inhibitor_Withdrawal.13.aspx
- Csoka AB, Shipko S. Persistent sexual side effects after SSRI discontinuation [Internet]. Psychother Psychosom. 2006;75(3):187–188. [cited 2021 Aug 28]. Available from: https://www.researchgate.net/profile/Antonei-Csoka/publication/7143554_Persistent_Sexual_Side_Effects_after_SSRI_Discontinuation/links/0912f50f6c1c70b998000000/Persistent-Sexual-Side-Effects-after-SSRI-Discontinuation.pdf
- Mollaioli D, Sansone A, Ciocca G, et al. Benefits of Sexual Activity on Psychological, Relational, and Sexual Health During the COVID-19 Breakout. J Sex Med [Internet]. 2021;18(1):35–49. Available from: https://doi.org/https://doi.org/10.1016/j.jsxm.2020.10.008
- Clayton AH, El Haddad S, Iluonakhamhe JP, et al. Sexual dysfunction associated with major depressive disorder and antidepressant treatment. Expert Opin Drug Saf. 2014;13:1361–1374.
- Caldiroli A, Capuzzi E, Tagliabue I, et al. Augmentative pharmacological strategies in treatment-resistant major depression: a comprehensive review. Int J Mol Sci [Internet]. 2021;22(23):13070. cited 2022 Mar 9. Available from]: https://www.mdpi.com/1422-0067/22/23/13070/htm
- Goldstein I. The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. Am J Cardiol Excerpta Medica. 2000;86(2):41–45.
- Feldman HA, Goldstein I, Hatzichristou DG, et al. Construction of a surrogate variable for impotence in the Massachusetts male aging study. J Clin Epidemiol [Internet]. 1994;47(5):457–467. cited 2021 Aug 28. Available from: https://pubmed.ncbi.nlm.nih.gov/7730871/
- Arborelius L, Owens MJ, Plotsky PM, et al. The role of corticotropin-releasing factor in depression and anxiety disorders [Internet]. J Endocrinol. 1999;160(1):1–12. [cited 2021 Aug 28]. Available from: https://pubmed.ncbi.nlm.nih.gov/9854171/
- Macchi C, Favero C, Ceresa A, et al. Depression and cardiovascular risk—association among Beck Depression Inventory, PCSK9 levels and insulin resistance. Cardiovasc Diabetol [Internet]. 2020;19(1):1–11. cited 2022 Mar 9. Available from: https://cardiab.biomedcentral.com/articles/10.1186/s12933-020-01158-6
- Baldwin DS, Thomas SC, Birtwistle J. Effects of antidepressant drugs on sexual function. Int J Psychiatry Clin Pract. [Internet]. 1997;1(1):47–58. cited 2021 Oct 7. Available from: https://pubmed.ncbi.nlm.nih.gov/24926981/
- Clayton AH, Pradko JF, Croft HA, et al. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry [Internet]. 2002;63:357–366. cited 2021 Oct 7. Available from: https://pubmed.ncbi.nlm.nih.gov/12000211/
- Montejo AL, Llorca G, Izquierdo JA, et al. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. J Clin Psychiatry [Internet]. 2001;62:10–21. cited 2021 Aug 29. Available from: https://www.psychiatrist.com/read-pdf/29646/
- Clayton AH, Reddy S, Focht K, et al. An evaluation of sexual functioning in employed outpatients with major depressive disorder treated with desvenlafaxine 50 mg or placebo. J Sex Med [Internet]. 2013;10(3):768–776. cited 2021 Oct 7. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1743-6109.2012.02899.x
- Trenque T, Maura G, Herlem E, et al. Reports of sexual disorders related to serotonin reuptake inhibitors in the French pharmacovigilance database: an example of underreporting. Drug Saf [Internet]. 2013;36(7):515–519. cited 2021 Oct 7. Available from: https://pubmed.ncbi.nlm.nih.gov/23728950/
- Clayton AH, Croft HA, Horrigan JP, et al. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry [Internet]. 2006;67(5):736–746. cited 2021 Aug 28. Available from: https://www.psychiatrist.com/jcp/depression/bupropion-extended-release-compared-escitalopram-effects/
- Coleman CC, Cunningham LA, Foster VJ, et al. Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment. Ann Clin Psychiatry. 1999;11(4):205–215.
- Clayton AH, Gommoll C, Chen D, et al. Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial. Int Clin Psychopharmacol [Internet]. 2015;30(4):216. cited 2021 Oct 7. Available from: /pmc/articles/PMC4457500/
- Alam MY, Jacobsen PL, Chen Y, et al. Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study. Int Clin Psychopharmacol [Internet]. 2014;29(1):36–44. cited 2021 Oct 7. Available from: /pmc/articles/PMC4235387/
- Mahableshwarkar AR, Jacobsen PL, Serenko M, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of 2 doses of vortioxetine in adults with major depressive disorder. J Clin Psychiatry [Internet]. 2015;76(5):583–591. cited 2021 Oct 7. Available from: https://www.psychiatrist.com/jcp/depression/randomized-double-blind-placebo-controlled-study-efficacy-safety-vortioxetine-2-doses-adults-mdd
- Garnock-Jones KP. Vortioxetine: a review of its use in major depressive disorder. CNS Drugs 289 [Internet]. 2014;28(9):855–874. cited 2021 Oct 7. Available from: https://link.springer.com/article/10.1007/s40263-014-0195-x
- Montejo AL, Prieto N, Terleira A, et al. Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale. J Psychopharmacol [Internet]. 2010;24(1):111–120. cited 2021 Oct 7. Available from: https://journals.sagepub.com/doi/abs/10.1177/0269881108096507?casa_token=UopvDPe3QjEAAAAA%3Akeh3slLQpQ5Sf0z5FeF5cFMoGX6BwUe9oxIX4TUxetxrnW1TwEPJWCnvGqsYTTM4cTiPGS-sAQ6lrck
- Clayton AH, Zajecka J, Ferguson JM, et al. Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder. Int Clin Psychopharmacol. 2003;18(3):151–156.
- Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. J Am Med Assoc [Internet]. 1999;281(6):537–544. cited 2021 Aug 17. Available from: https://pubmed.ncbi.nlm.nih.gov/10022110/
- Casper RC, Redmond, DE, Katz, MM, et al. Somatic symptoms in primary affective disorder: presence and relationship to the classification of depression. Arch Gen Psychiatry [Internet]. 1985;42(11):1098–1104. cited 2021 Aug 17. Available from: https://pubmed.ncbi.nlm.nih.gov/3863548/
- Ashton AK, Hamer R, Rosen RC. Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: a large-scale retrospective study of 596 psychiatric outpatients. J Sex Marital Ther. [Internet]. 1997;23(3):165–175. cited 2021 Aug 30. Available from: https://www.tandfonline.com/doi/abs/10.1080/00926239708403922
- Pollack MH, Reiter S, Hammerness P. Genitourinary and sexual adverse effects of psychotropic medication [Internet]. Int J Psychiatry Med. SAGE PublicationsSage CA: Los Angeles, CA. 1992;22(4):p. 305–327. [cited 2021 Aug 30]. Available from: https://journals.sagepub.com/doi/abs/10.2190/P60R-PLED-TL09-TUEN
- Pyke RE. Trazodone in sexual medicine: underused and overdosed? Sex Med Rev. 2020;8(2):206–216.
- Monteiro WO, Noshirvani HF, Marks IM, et al. Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial. Br J Psychiatry [Internet]. 1987;151(1):107–112. cited 2021 Aug 28. Available from: https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/abs/anorgasmia-from-clomipramine-in-obsessivecompulsive-disorder/3747DA42C974CF6943CFA8F12AB03A7C
- Harrison WM, Rabkin JG, Ehrhardt AA, et al. Effects of antidepressant medication on sexual function: a controlled study. J Clin Psychopharmacol [Internet]. 1986;6(3):144–149. cited 2021 Aug 28. Available from: https://europepmc.org/article/med/3711364
- Liu G, Yin Y, Zhang L, et al. Efficacy of dapoxetine in the treatment of patients with lifelong premature ejaculation as an alternative to sertraline therapy. Sex Med [Internet]. 2022;10(1). cited 2022 Mar 9. Available from: https://pubmed.ncbi.nlm.nih.gov/34968812/
- Shabsigh R, Klein LT, Seidman S, et al. Increased incidence of depressive symptoms in men with erectile dysfunction. Urology [Internet]. 1998;52(5):848–852. cited 2021 Aug 28. Available from: https://www.sciencedirect.com/science/article/pii/S0090429598002921
- Labbate LA, Grimes J, Hiaes A, et al. Sexual dysfunction induced by serotonin reuptake antidepressants. J Sex Marital Ther [Internet]. 1998;24(1):3–12. cited 2021 Aug 30. Available from: https://www.tandfonline.com/doi/abs/10.1080/00926239808414663
- Segraves RT, Balon R. Recognizing and reversing sexual side effects of medications. In Handbook of clinical sexuality for mental health professionals, pp–311. New York: Brunner-Routledge. 2010.
- Montejo-Gonzalez AL, Liorca G, Izquierdo JA, et al. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther [Internet]. 1997;23(3):176–194. cited 2021 Aug 30. Available from: https://www.researchgate.net/profile/Angel-Montejo/publication/13928039_SSRI-induced_sexual_dysfunction_Fluoxetine_paroxetine_sertraline_and_fluvoxamine_in_a_prospective_multicenter_and_descriptive_clinical_study_of_344_patients/links/0912f502172e7931d300
- Bonierbale M , and Tignol J. The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France. Curr Med Res Opin. 2003;19(2):114–124.
- Lai CH. Bupropion-related sexual dysfunction and possible management in a fresh patient with major depressive disorder. J Neuropsychiatry Clin Neurosci. 2014;26(2):18–19.
- Haberfellner EM. A review of the assessment of antidepressant-induced sexual dysfunction used in randomized, controlled clinical trials [Internet]. Pharmacopsychiatry. © Georg Thieme Verlag KG Stuttgart · New York. 2007;40(5):p. 173–182. [cited 2021 Sep 5]. Available from: http://www.thieme-connect.com/products/ejournals/html/10.1055/s-2007-985881
- Althof SE, Needle RB. Psychological factors associated with male sexual dysfunction: screening and treatment for the urologist. Urol Clin North Am. 2011;38(2):141–146.
- McGahuey CA, Gelenberg AJ, Laukes CA, et al. The Arizona sexual experience scale (Asex): reliability and validity. J Sex Marital Ther [Internet]. 2000;26(1):25–38. cited 2021 Nov 17. Available from: https://pubmed.ncbi.nlm.nih.gov/10693114/
- Clayton AH, McGarvey EL, Clavet GJ. The changes in sexual functioning questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol Bull [Internet]. 1997;33(4):731–745. [cited 2021 Nov 17]. Available from: https://pubmed.ncbi.nlm.nih.gov/9493486/
- Keller A, McGarvey EL, Clayton AH. Reliability and construct validity of the changes in sexual functioning questionnaire short-form (CSFQ-14). J Sex Marital Ther [Internet]. 2006;32(1):43–52. cited 2021 Nov 18. Available from: https://pubmed.ncbi.nlm.nih.gov/16234225/
- Montejo ÁL, Rico-Villademoros F. Psychometric properties of the psychotropic-related sexual dysfunction questionnaire (PRSexDQ-SALSEX) in patients with schizophrenia and other psychotic disorders. J Sex Marital Ther. 2008;34(3):227–239.
- Kennedy SH, Rizvi SJ, Fulton K, et al. The sex effects scale: pilot validation in a healthy population. Psychopharmacol Bull [Internet]. 2010;43:15–25. cited 2021 Nov 18. Available from: https://pubmed.ncbi.nlm.nih.gov/21150843/
- Derogatis LR, Melisaratos N. The DSFI: a multidimensional measure of sexual functioning. J Sex Marital Ther. [Internet]. 1979;5(3):244–281. cited 2021 Nov 18. Available from: https://pubmed.ncbi.nlm.nih.gov/513144/
- Labbate LA, Lare SB. Sexual dysfunction in male psychiatric outpatients: validity of the Massachusetts general hospital sexual functioning questionnaire. Psychother Psychosom. [Internet]. 2001;70(4):221–225. cited 2021 Nov 18. Available from: https://pubmed.ncbi.nlm.nih.gov/11408842/
- Zajecka J, Mitchell S, Fawcett J. Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the rush sexual inventory. Psychopharmacol Bull [Internet]. 1997;33(4):p. 755–760. [cited 2021 Nov 18]. Available from: https://pubmed.ncbi.nlm.nih.gov/9493488/
- Melnik T, Soares BGO, Nasello AG. The effectiveness of psychological interventions for the treatment of erectile dysfunction: systematic review and meta-analysis, including comparisons to sildenafil treatment, intracavernosal injection, and vacuum devices. J Sex Med. 2008;5(11):2562–2574.
- Rosen RC, Leiblum SR, Spector IP. Psychologically based treatment for male erectile disorder: a cognitive-interpersonal model. J Sex Marital Ther. 1994;20(2):67–85.
- Zilbergeld B. The new male sexuality. New York, US: Bantam; 1999.
- Schover LR. Prime time: sexual health for men over fifty. New York, US: Henry Holt \& Company; 1984.
- Rothschild AJ. Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry [Internet]. 1995;152:1514–1516. cited 2021 Nov 18. Available from: https://pubmed.ncbi.nlm.nih.gov/7573593/
- Ferguson JM, Shrivastava RK, Stahl SM, et al. Reemergence of sexual dysfunction in patients with major depressive disorder double-blind comparison of nefazodone and sertraline. J Clin Psychiatry [Internet]. 2001;62(1):24–29. cited 2021 Nov 18. Available from: https://pubmed.ncbi.nlm.nih.gov/11235924/
- Gelenberg AJ, Laukes C, McGahuey C, et al. Mirtazapine substitution in SSRI-induced sexual dysfunction. J Clin Psychiatry [Internet]. 2000;61(5):356–360. cited 2021 Nov 18. Available from: https://pubmed.ncbi.nlm.nih.gov/10847310/
- Walker PW, Cole JO, Gardner EA, et al. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J Clin Psychiatry [Internet]. 1993;54:459–465. cited 2021 Nov 18. Available from: https://pubmed.ncbi.nlm.nih.gov/8276736/
- Evliyaoǧlu Y, Yelsel K, Kobaner M, et al. Efficacy and tolerability of tadalafil for treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Urology. 2011;77(5):1137–1141.
- Rosen R, Shabsigh R, Berber M, et al. Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response study. Am J Psychiatry [Internet]. 2006;163(1):79–87. cited 2021 Sep 6. Available from: https://ajp.psychiatryonline.org/doi/abs/10.1176/appi.ajp.163.1.79
- Smith KM, Romanelli F. Recreational use and misuse of phosphodiesterase 5 inhibitors [Internet]. J Am Pharm Assoc. 2005;45(1):63–75. [cited 2021 Aug 29]. Available from: https://www.sciencedirect.com/science/article/pii/S1544319115317441
- Sadovsky R, Miller T, Moskowitz M, et al. Three-year update of sildenafil citrate (Viagra) efficacy and safety. Int J Clin Pract [Internet]. 2001;55:115–128. cited 2021 Aug 29. Available from: https://europepmc.org/article/med/11321851
- Nurnberg HG, Hensley PL, Gelenberg AJ, et al. Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. J Am Med Assoc. 2003;289(1):56–64.
- Fava M, Nurnberg HG, Seidman SN, et al. Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry [Internet]. 2006;67(2):240–246. cited 2021 Nov 20. Available from: https://pubmed.ncbi.nlm.nih.gov/16566619/
- Nurnberg HG, Gelenberg A, Hargreave TB, et al. Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Am J Psychiatry. 2001;158(11):1926–1928.
- Fava M, Rankin MA, Alpert JE, et al. An open trial of oral sildenafil in antidepressant-induced sexual dysfunction. Psychother Psychosom. 1998;67(6):328–331.
- Tignol J, Furlan PM, Gomez-Beneyto M, et al. Efficacy of sildenafil citrate (Viagra®) for the treatment of erectile dysfunction in men in remission from depression. Int Clin Psychopharmacol. 2004;19(4):191–199.
- Nurnberg HG, Fava M, Gelenberg AJ, et al. Open-label sildenafil treatment of partial and non-responders to double-blind treatment in men with antidepressant-associated sexual dysfunction. Int J Impot Res. 2007;19(2):167–175.
- Segraves RT, Lee J, Stevenson R, et al. Tadalafil for treatment of erectile dysfunction in men on antidepressants. J Clin Psychopharmacol. 2007;27(1):62–66.
- Choi JB, Cho KJ, Kim JC, et al. An open-label, single-arm pilot study to evaluate the efficacy of daily low dose tadalafil on depression in patients with erectile dysfunction. Transl Androl Urol. 2019;8(5):501–506.
- Safarinejad MR. The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study. BJU Int. [Internet]. 2010 ;106(6):840–847. cited 2021 Aug 29. Available from: https://www.academia.edu/download/59950947/73-Bupropion_in_SSRI_induced_male_SD20190707-21824-17s6lzm.pdf
- Clayton AH, Warnock JK, Kornstein SG, et al. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry [Internet]. 2004;65(1):62–67. cited 2021 Sep 6. Available from: https://www.psychiatrist.com/jcp/depression/sexual-dysfunction/placebo-controlled-trial-bupropion-sr-antidote-selective
- Bossini L, Casolaro I, Koukouna D, et al. Off-label uses of trazodone: a review. Expert Opin Pharmacother. 2012;13(12):1707–1717.
- Bernik M, Vieira AHG, Nunes PV. Bethanecol chloride for treatment of clomipramine-induced orgasmic dysfunction in males. Rev Hosp Clin Fac Med Sao Paulo. 2004;59(6):357–360.
- Pae CU, Marks DM, Masand PS, et al. Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial. Clin Neuropharmacol. 2009;32(2):85–88.
- Baldwin D, Hutchison J, Donaldson K, et al. Selective serotonin reuptake inhibitor treatment-emergent sexual dysfunction: randomized double-blind placebo-controlled parallel-group fixed-dose study of a potential adjuvant compound, VML-670. J Psychopharmacol. 2008;22(1):55–63.
- Dording CM, Fisher L, Papakostas G, et al. A double-blind, randomized, pilot dose-finding study of maca root (L. Meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neurosci Ther [Internet]. 2008;14(3):182–191. cited 2021 Sep 6. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1755-5949.2008.00052.x
- Cohen AJ, Bartlik B. Ginkgo biloba for antidepressant-induced sexual dysfunction. J Sex Marital Ther. [Internet]. 1998;24(2):139–143. cited 2021 Sep 6. Available from: https://www.tandfonline.com/doi/abs/10.1080/00926239808404927